Mobile

Randomised phase II study of the combination of oral vinorelbine with capecitabine versus gemcitabine in combination with paclitaxel versus gemcitabine in combination with docetaxel as first line chem...

Mise à jour : Il y a 4 ans
Référence : EUCTR2005-000438-19

Randomised phase II study of the combination of oral vinorelbine with capecitabine versus gemcitabine in combination with paclitaxel versus gemcitabine in combination with docetaxel as first line chemotherapy in patients with metastatic breast cancer

Femme Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To evaluate simultaneously the Overall Response Rates (ORR) of oral vinorelbine in combination with capecitabine, gemcitabine in combination with paclitaxel and gemcitabine in combination with docetaxel in HER2 negative metastatic breast cancer patients

Critère d'inclusion

  • First line chemotherapy in patients with metastatic breast cancer

Liens